Which of the following is the correct way to write the date in the American format?

Choice A reason: This test measures the level of antibodies that the body produces against the streptolysin O enzyme, which is produced by some strains of streptococcal bacteria. A high level of ASO titer indicates that the child had a recent streptococcal infection, which may trigger rheumatic fever in some cases.

Choice B reason: This test does not directly indicate if the child has rheumatic fever. Rheumatic fever is a complication of untreated or inadequately treated streptococcal infection, which causes inflammation of the heart, joints, skin, and brain. The diagnosis of rheumatic fever is based on clinical criteria, such as the presence of carditis, polyarthritis, chorea, erythema marginatum, or subcutaneous nodules.

Choice C reason: This test does not confirm if the child has immunity to streptococcal bacteria. Immunity is the ability of the body to resist or fight off an infection. A high level of ASO titer does not mean that the child is immune to streptococcal bacteria, but rather that the child was exposed to them recently.

Choice D reason: This test does not indicate if the child has a therapeutic blood level of an aminoglycoside. Aminoglycosides are a class of antibiotics that are used to treat serious bacterial infections, such as endocarditis or septicemia. The blood level of an aminoglycoside is measured by a different test, called a peak and trough level, which determines the effectiveness and safety of the drug.

Choice A reason: A 24-gauge catheter is appropriate for a small and fragile vein of a 12-month-old infant. It minimizes the risk of damaging the vein and ensures the comfort of the infant during IV therapy.

Choice B reason: Starting an IV in the infant's foot is not the first choice due to the risk of movement dislodging the catheter. The hand or the antecubital fossa are preferred sites for IV insertion in infants.

Choice C reason: While it is important to cover the IV insertion site, an opaque dressing is not necessary. A transparent dressing is preferred as it allows for continuous visibility of the site for signs of infection or phlebitis.

Choice D reason: The IV site should not be routinely changed every 3 days. It should be changed based on clinical indications such as signs of infection, infiltration, or phlebitis, or if the IV becomes dislodged.